alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
         This schedule contains summary financial information extracted from the
financial statements of Realmark Property Investors Limited Partnership VI-B for
the three months ended March 31, 1999, and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER>                                    1

<S>                                            <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                      DEC-31-1999
<PERIOD-START>                         JAN-01-1999
<PERIOD-END>                           MAR-31-1999
<CASH>                                     739,545
<SECURITIES>                                     0
<RECEIVABLES>                              122,257
<ALLOWANCES>                                     0
<INVENTORY>                                      0
<CURRENT-ASSETS>                         1,194,685
<PP&E>                                   7,064,582
<DEPRECIATION>                           1,935,963
<TOTAL-ASSETS>                           6,838,175
<CURRENT-LIABILITIES>                      331,811
<BONDS>                                  5,277,930
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                         0
<OTHER-SE>                                       0
<TOTAL-LIABILITY-AND-EQUITY>             6,838,175
<SALES>                                          0
<TOTAL-REVENUES>                           462,188
<CGS>                                            0
<TOTAL-COSTS>                              612,544
<OTHER-EXPENSES>                            34,226
<LOSS-PROVISION>                                 0
<INTEREST-EXPENSE>                         112,597
<INCOME-PRETAX>                           (184,582)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                              0
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                              (184,582)
<EPS-BASIC>                                (2.28)
<EPS-DILUTED>                                    0


</TABLE>
# Drill #11

&"Times New Roman,Bold"Helitack - Bucket/Fixed Tank Operations		&"Times New Roman,Bold"Drill #11

&P	

&P	

# Code Page

# image1.png
# National Hurricane Preparedness Week, 2009

Each year, hurricanes threaten the safety of American families in coastal and inland communities. These powerful storms can cause heavy rainfall, high winds, tornadoes, and storm surges, which can in turn bring severe flooding, power outages, damage to homes and businesses, and loss of life.

Awareness and preparation are critical to surviving and recovering from hurricanes. During National Hurricane Preparedness Week, I call on all Americans—including private citizens and those working in government, business, and the nonprofit sector—to plan ahead and help secure the safety and property of those who face advancing storms.

Americans can take basic steps before a hurricane arrives. The Federal Emergency Management Agency and the National Hurricane Center recommend developing a family disaster plan, creating and maintaining a disaster supply kit, securing one’s home, and designating a safe place to go during a storm. Throughout a storm, individuals should always remain aware of weather conditions. More information on precautionary measures is available at www.nhc.noaa.gov/​HAW2/​english/​intro.shtml.

Organizations at the local, State, and national level play important roles to protect Americans from the effects of hurricanes. Rescue and relief organizations, the private sector, and the news media work to meet demands that emerge before, during, and after a hurricane. Among other services, they distribute safety information and help coordinate relief activities. My Administration is committed to strengthening these efforts and is working every day to prepare for hurricanes and their potential impacts on everyone in the United States.

The threat hurricanes pose to lives and property cannot be eliminated, but preparedness can reduce the dangers these storms pose for our families and communities.

NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, by virtue of the authority vested in me by the Constitution and laws of the United States do hereby proclaim May 24 through May 30, 2009, as National Hurricane Preparedness Week. I call upon government agencies, private organizations, media, community groups, schools, and residents of hurricane-prone areas to share information about hurricane preparedness and response to help protect communities and save lives.

IN WITNESS WHEREOF, I have hereunto set my hand this twenty-sixth day of May, in the year of our Lord two thousand nine, and of the Independence of the United States of America the two hundred and thirty-third.

[FR Doc. E9-12648

Billing code 3195-W9-P
Exhibit 10.2


 


AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT


 


AMENDMENT No. 2
dated as of August 3, 2022 between Titan Pharmaceuticals, Inc. (the “Company”) and Katherine Beebe DeVarney
(“Executive”).


 


WHEREAS, the Company and Executive are parties
to an employment agreement dated November 1, 2018 (as amended in February 2021, the “Employment Agreement”); and


 


WHEREAS, the Company and Executive wish to amend
the Employment Agreement in connection with a retention plan adopted by the compensation committee of the board of directors of the Company.


 


NOW, THEREFORE, for and in consideration of the
premises and the mutual covenants hereinafter set forth, the parties hereto do hereby agree as follows. Capitalized terms not defined
herein shall have the meanings set forth in the Employment Agreement.


 


1.            Definitions.


 


a.     Cause.
Section 4.6.2 of the Employment Agreement is hereby amended to delete the words “Senior
Vice” in the last sentence.


 


b.     Good
Reason. Section 4.6.3(iii) of the Employment Agreement is hereby to amended to read in its entirety as follows:


 


“(iii) a material diminution
in Executive's duties, authority or responsibilities;”


 


c.     Change
of Control. Section 4.6.4 of the Employment Agreement is hereby amended by adding the following sentence:


 


“In addition, solely for the purpose
of the immediate acceleration of unvested options pursuant to Section 4.5 hereof, Change of Control shall also mean the election
to the board of directors of a slate nominated by any stockholder that is equal to or exceeds the number of directors constituting the
board immediately prior to such election.”


 


2.            Miscellaneous.
Except as expressly amended by this Amendment, the Employment Agreement remains in full force and effect.


 






    	 	 	 



     


    

 


IN WITNESS WHEREOF, the parties hereto have caused
this Amendment to be duly executed as of the day and year first above written.


 





	TITAN PHARMACEUTICALS, INC.	 
	 	 
	By:	 	 
	 	Name:	M. David MacFarlane, Ph.D.	 
	 	Title:	Chairman. Compensation Committee	 
	 	 
	EXECUTIVE	 
	 	 
	 	Name:	Kate Beebe DeVarney, Ph.D.
**EXHIBIT 99.1**

 

**CERTIFICATION PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

**(18 U.S.C. SECTION 1350)**

 

In connection with the Annual Report of Ventana Medical Systems, Inc., a Delaware corporation (the “Company”), on Form 10-K for the year ending December 31, 2002 as filed with the Securitiesand Exchange Commission (the “Report”), I, Christopher M. Gleeson, Chief Executive Officer of the Company, certify, pursuant to § 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. § 1350), that to my knowledge: 

 

(1) The Report fully complies with the requirements of section13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 282 Introduced in Senate (IS)]

111th CONGRESS
  1st Session
                                 S. 282

To authorize the extension of nondiscriminatory treatment (normal trade 
          relations treatment) to the products of Kazakhstan.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 21, 2009

   Mr. Lugar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To authorize the extension of nondiscriminatory treatment (normal trade 
          relations treatment) to the products of Kazakhstan.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TERMINATION OF APPLICATION OF TITLE IV OF THE TRADE ACT OF 
              1974 TO THE PRODUCTS OF KAZAKHSTAN.

    (a) Presidential Determinations and Extension of Nondiscriminatory 
Treatment.--Notwithstanding any provision of title IV of the Trade Act 
of 1974 (19 U.S.C. 2431 et seq.), the President may--
            (1) determine that the denial of nondiscriminatory 
        treatment should no longer apply to the products of Kazakhstan; 
        and
            (2) after making a determination under paragraph (1) with 
        respect to Kazakhstan, proclaim the extension of 
        nondiscriminatory treatment (normal trade relations treatment) 
        to the products of Kazakhstan.
    (b) Termination of Applicability of Title IV.--On and after the 
date on which the President extends nondiscriminatory treatment to the 
products of Kazakhstan pursuant to subsection (a), title IV of the 
Trade Act of 1974 shall cease to apply to Kazakhstan.
                                 <all>
```
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

CHARLENE BARKER,

Appellant,

v.

COMPOUNDING DOCS, INC.,

Appellee.

No. 4D16-3662

[February 14, 2019]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Sandra Perlman, Judge; L.T. Case No. 15-003589.

Kenneth S. Mair of Law Offices of Kenneth Mair, Fort Lauderdale, for 

appellant.

Elaine D. Walter and Joseph M. Winsby of Gaebe, Mullen, Antonelli & 

DiMatteo, Coral Gables, for appellee.

PER CURIAM.

Affirmed.

GROSS, CONNER and FORST, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

REGINALD D. EVANS, 

Plaintiff-Appellant,

v.  No. 00-2266

LOUIS CALDERA, Secretary of the

United States Army,

Defendant-Appellee. 

Appeal from the United States District Court

for the District of South Carolina, at Columbia.

Joseph F. Anderson, Jr., Chief District Judge;

Joseph B. McCrorey, Magistrate Judge.

(CA-99-865-3-17-BC)

Submitted: April 30, 2001

Decided: June 11, 2001

Before WIDENER, WILKINS, and MOTZ, Circuit Judges.

Vacated and remanded by unpublished per curiam opinion.

COUNSEL

Reginald D. Evans, Appellant Pro Se. Barbara Murcier Bowens,

OFFICE OF THE UNITED STATES ATTORNEY, Columbia, South

Carolina, for Appellee.
Unpublished opinions are not binding precedent in this circuit. See

Local Rule 36(c). 

OPINION

PER CURIAM: 

Reginald D. Evans appeals the magistrate judge’s* order granting

summary judgment to Defendant in this employment discrimination

action. For the reasons set forth below, we vacate and remand for further proceedings. 

A review of the record discloses that both Evans and Defendant

moved for summary judgment, and that Defendant submitted depositions, affidavits, and other materials in support of his motion. The

magistrate judge granted summary judgment to Defendant, but did not

provide Evans with the notice required by Roseboro v. Garrison, 528

F.2d 309, 310 (4th Cir. 1975). Roseboro prohibits the entry of summary judgment based on a pro se party’s failure to submit affidavits

supporting his allegations unless such party is given a reasonable

opportunity to file counter-affidavits or other appropriate materials

and is informed that failure to file such a response may result in dismissal of the action. Id.

Although Evans responded to Defendant’s summary judgment

motion, he did not submit any affidavits in support of his claims. The

magistrate judge granted Defendant’s motion for summary judgment,

in part, based on Evans’ failure to produce such supporting evidence.

On this record, we cannot find that the magistrate judge’s failure to

provide Roseboro notice was harmless error. See Fed. R. Civ. P. 61;

Fed. R. Civ. P. 56(e). We therefore vacate the magistrate judge’s

order granting summary judgment to Defendant and remand this case

with instructions to provide Evans with the notice and opportunity to

respond required by Roseboro. 

*The parties consented to the jurisdiction of a United States magistrate

judge pursuant to 28 U.S.C. § 636(c) (1994), and Fed. R. Civ. P. 73. 

2 EVANS v. CALDERA
We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and

argument would not aid the decisional process. The reason for remand

is entirely procedural and is unrelated to the merits of the case.

VACATED AND REMANDED

EVANS v. CALDERA 3
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-21-00195-CV

In re Leslie Ray Turner

ORIGINAL PROCEEDING FROM SAN SABA COUNTY

M E M O R A N D U M O P I N I O N 

Relator has filed a petition for writ of mandamus complaining of the trial court’s 

failure to rule on his petition pending in the district court. On this record, having reviewed the 

relator’s petition for writ of mandamus, we deny the petition for writ of mandamus. See Tex. R. 

App. P. 52.8(a).

__________________________________________

Darlene Byrne, Chief Justice

Before Chief Justice Byrne, Justices Baker and Smith

Filed: April 30, 2021
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>                       5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               DEC-31-1995
<PERIOD-END>                    SEP-30-1995
<CASH>                          187,362
<SECURITIES>                    0
<RECEIVABLES>                   0
<ALLOWANCES>                    0
<INVENTORY>                     0
<CURRENT-ASSETS>                0
<PP&E>                          0
<DEPRECIATION>                  0
<TOTAL-ASSETS>                  187,362
<CURRENT-LIABILITIES>           0
<BONDS>                         0
<COMMON>                        0
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<OTHER-SE>                      90,169
<TOTAL-LIABILITY-AND-EQUITY>    187,362
<SALES>                         0
<TOTAL-REVENUES>                8,001
<CGS>                           0
<TOTAL-COSTS>                   0
<OTHER-EXPENSES>                49,242
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              0
<INCOME-PRETAX>                 0
<INCOME-TAX>                    0
<INCOME-CONTINUING>             0
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-LOSS>                      (41,241)
<EPS-PRIMARY>                   (.03)
<EPS-DILUTED>                   0
        

</TABLE>
Exhibit 32.1**CERTIFICATION****1**     Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the UnitedStates Code (18 U.S.C. § 1350), Timothy P. Walbert, the President and Chief ExecutiveOfficer of IDM Pharma, Inc. (the “Company”), and Robert J. De Vaere, the Senior Vice President andChief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:**1.**The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2007, to which thisCertification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with therequirements of Section 13(a) or Section 15(d) of the Exchange Act; and**2.**The information contained in the Periodic Report fairly presents, in all material respects, thefinancial condition of the Company at the end of the period covered by the Periodic Report andresults of operations of the Company for the period covered by the Periodic Report.Dated: August 10, 2007       /s/ Timothy P. Walbert Timothy P. Walbert   /s/ Robert J. De Vaere Robert J. De Vaere  President and Chief Executive Officer   Senior Vice President and Chief Financial Officer   1 This certification accompanies the Form10-Q to which it relates, is not deemed filed with the Securities and ExchangeCommission and is not to be incorporated by reference into any filing of IDMPharma, Inc. under the Securities Act of 1933, as amended, or the SecuritiesExchange Act of 1934, as amended (whether made before or after the date of theForm 10-Q), irrespective of any general incorporation language contained insuch filing.
<PAGE>

                                                                  Exhibit 23

                  CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
                  -----------------------------------------

We consent to the incorporation by reference in Registration Statement Nos.
33-5524, 33-22850, 2-77932, 2-97291, 33-625, 33-45410, 33-53971, 33-59781,
333-82847 and 33-50960 of Angelica Corporation on Form S-8 of our report
dated April 7, 2004, relating to the consolidated financial statements of
Angelica Corporation and subsidiaries as of and for the year ended January
31, 2004 (which report expresses an unqualified opinion and includes
explanatory paragraphs relating to (1) the adoption of new accounting
principles and (2) the application of procedures relating to certain
disclosures of financial statement amounts related to the January 26, 2002
financial statements that were audited by other auditors who have ceased
operations and for which we have expressed no opinion or other form of
assurance other than with respect to such disclosures) appearing in this
Annual Report on Form 10-K of Angelica Corporation for the year ended
January 31, 2004.


/s/ DELOITTE & TOUCHE LLP
St. Louis, Missouri
April 15, 2004
Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 08-10748

Conference Calendar

UNITED STATES OF AMERICA

Plaintiff-Appellee

v.

DUSTY LEE LARGE

Defendant-Appellant

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 6:08-CR-10-1

Before JONES, Chief Judge, and JOLLY and ELROD, Circuit Judges.

PER CURIAM:*

The Federal Public Defender appointed to represent Dusty Lee Large has

moved for leave to withdraw and has filed a brief in accordance with Anders v.

California, 386 U.S. 738 (1967). Large has not filed a response. Our

independent review of the record and counsel’s brief discloses no nonfrivolous

issue for appeal. Accordingly, counsel’s motion for leave to withdraw is

GRANTED, counsel is excused from further responsibilities herein, and the

APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

United States Court of Appeals

Fifth Circuit

F I L E D

April 30, 2009

Charles R. Fulbruge III

Clerk
##### 



EXHIBIT 99.1 CALCULATION OF THE
MAXIMUM NOTES BALANCE AT MARCH 31, 2005 UNDER THE SENIOR SECURED
NOTES FACILITY DATED JANUARY 13, 2005 I. Lesser of:A. the product of:1. the Free Cash Flow Multiple
    
    
    9.5xMultiplied by2. Services Business Free Cash Flow
    
    $
    5,481$
    52,070OrB. the product of:x. 2.0 times
    
    
    2.0xmultiplied byy. Services Business Revenue
    
    $
    16,595$
    33,191II. Lesser of1. 50% of the results of the immediately preceding clause (I)
    
    
    
    
    
    $
    16,595Or2. 30% of the Companys After-tax PV10
    
    
    
    
    
    $
    7,114III. 10% of the Companys After-tax PV10
    
    
    
    
    
    $
    2,371Maximum Notes Balance = (I) + (II) + (III)
    
    
    
    
    
    $
    42,676Aggregate Notes Outstanding at Determination Date
    
    
    
    
    
    $
    30,000Companys After-tax PV10 as of 12/31/04
    
    
    
    
    
    $
    23,712Services Business Revenue {Section 2(a)(xxxx)}
    
    
    
    
    
    $
    16,595Services Business operating income
    
    $
    4,106Services Business depreciation and amortization expense
    
    
    1,375Less: Any net operating income from affiliates
    
    
    (A) Services Business net operating income before interest, taxes,
    
    
    
    
    
    $
    5,481(B) Aggregate interest paid on permitted indebtedness
    
    
    
    
    
    
    340Services Business capital expenditures
    
    $
    3,224Less: Issuances of stock by Infinity, less costs
    
    
    (9,265
    )0Less: Aggregate interest expense
    
    
    (340
    )Services Business capital expenditures, not funded
    
    
    (340
    )
    
    
    (340
    )Services Free Cash Flow {Section 2(a)(xxxix)}
    
    
    
    
    
    $
    5,481
 33